DPIA has been identified by trusted drug-checking services in 212 published analytical results during 2015, 2016, 2017, 2018, 2019, 2022, 2023, 2024, 2025, 2026. These warnings establish its presence in submitted samples, but the aggregated alert evidence does not provide enough substance-specific information to describe effects, potency, or dosage.
DPIA molecular structure diagram from the DrugsPRO substance library.
Also known as: di-(beta-phenylisopropyl)amine, Di-(ß-phenylisopropyl)amine
Classification
Psychoactive: Stimulant
Tag: Precursor
Effects
No data available for this section yet.
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
No external data sources listed for this substance yet.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
DPIA - Treoir substainte DrugsPRO
DPIA: DPIA has been identified by trusted drug-checking services in 212 published analytical results during 2015, 2016, 2017, 2018, 2019, 2022, 2023, 2024, 2025, 2026. These warnings establish its presence in submitted samples, but the aggregated alert evidence does not provide enough substance-spec